These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16148424)

  • 1. A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis.
    Gulliver WP; Donsky HJ
    Am J Ther; 2005; 12(5):398-406. PubMed ID: 16148424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of mild to moderate psoriasis with Reliéva, a Mahonia aquifolium extract--a double-blind, placebo-controlled study.
    Bernstein S; Donsky H; Gulliver W; Hamilton D; Nobel S; Norman R
    Am J Ther; 2006; 13(2):121-6. PubMed ID: 16645428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, vehicle-controlled, half-side comparison with a herbal ointment containing Mahonia aquifolium, Viola tricolor and Centella asiatica for the treatment of mild-to-moderate atopic dermatitis.
    Klövekorn W; Tepe A; Danesch U
    Int J Clin Pharmacol Ther; 2007 Nov; 45(11):583-91. PubMed ID: 18077922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the Efficacy and Safety of Topical
    Janeczek M; Moy L; Lake EP; Swan J
    J Clin Aesthet Dermatol; 2018 Dec; 11(12):42-47. PubMed ID: 30666279
    [No Abstract]   [Full Text] [Related]  

  • 5. Plant extracts for the topical management of psoriasis: a systematic review and meta-analysis.
    Deng S; May BH; Zhang AL; Lu C; Xue CC
    Br J Dermatol; 2013 Oct; 169(4):769-82. PubMed ID: 23909714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical Botanical Agents for the Treatment of Psoriasis: A Systematic Review.
    Farahnik B; Sharma D; Alban J; Sivamani RK
    Am J Clin Dermatol; 2017 Aug; 18(4):451-468. PubMed ID: 28289986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliéva, a Mahonia aquifolium extract for the treatment of adult patients with atopic dermatitis.
    Donsky H; Clarke D
    Am J Ther; 2007; 14(5):442-6. PubMed ID: 17890932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
    Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
    Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Mahonia aquifolium ointment on the expression of adhesion, proliferation, and activation markers in the skin of patients with psoriasis.
    Augustin M; Andrees U; Grimme H; Schöpf E; Simon J
    Forsch Komplementarmed; 1999 Apr; 6 Suppl 2():19-21. PubMed ID: 10352377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids.
    Slobodníková L; Kost'álová D; Labudová D; Kotulová D; Kettmann V
    Phytother Res; 2004 Aug; 18(8):674-6. PubMed ID: 15476315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mahonia aquifolium in patients with psoriasis vulgaris - an intraindividual study.
    Wiesenauer M; Lüdtke R
    Phytomedicine; 1996 Nov; 3(3):231-5. PubMed ID: 23195075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
    Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J
    J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for nail psoriasis.
    de Vries AC; Bogaards NA; Hooft L; Velema M; Pasch M; Lebwohl M; Spuls PI
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007633. PubMed ID: 23440816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antipsoriatic Mahonia aquifolium and its active constituents; II. Antiproliferative activity against cell growth of human keratinocytes.
    Müller K; Ziereis K; Gawlik I
    Planta Med; 1995 Feb; 61(1):74-5. PubMed ID: 7700998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.
    Menter A; Gordon K; Carey W; Hamilton T; Glazer S; Caro I; Li N; Gulliver W
    Arch Dermatol; 2005 Jan; 141(1):31-8. PubMed ID: 15655139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients.
    Abrouk M; Nakamura M; Zhu TH; Farahnik B; Koo J; Bhutani T
    J Dermatolog Treat; 2017 Sep; 28(6):488-491. PubMed ID: 28042711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential antimutagenic activity of berberine, a constituent of Mahonia aquifolium.
    Cernáková M; Kost'álová D; Kettmann V; Plodová M; Tóth J; Drímal J
    BMC Complement Altern Med; 2002 Feb; 2():2. PubMed ID: 11943071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Novel Topical Liposomal Formulation of Cyclosporine in Mild to Moderate Stable Plaque Psoriasis: A Randomized Clinical Trial.
    Kumar R; Dogra S; Amarji B; Singh B; Kumar S; Sharma ; Vinay K; Mahajan R; Katare OP
    JAMA Dermatol; 2016 Jul; 152(7):807-15. PubMed ID: 27096709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study.
    Naldi L; Yawalkar N; Kaszuba A; Ortonne JP; Morelli P; Rovati S; Mautone G
    Am J Clin Dermatol; 2011 Jun; 12(3):191-201. PubMed ID: 21284407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.